Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells

Journal of Molecular and Cellular Cardiology

Volumn 46, Issue 2, 2009, Pages 234-240

  Holy, Erik W ^a,b   Akhmedov, Alexander ^a   Lüscher, Thomas F ^a,b   Tanner, Felix C ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Berberine; mRNA Stability; Simvastatin; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

BERBERINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; SIMVASTATIN; STRESS ACTIVATED PROTEIN KINASE; THROMBIN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; DRUG ANTAGONISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; HALF LIFE TIME; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; THROMBOSIS;

ANIMALS; AORTA; BERBERINE; CELL LINE; EPITHELIAL CELLS; HUMANS; HYPOLIPIDEMIC AGENTS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPROTEINS; MALE; MICE; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; RNA STABILITY; SIMVASTATIN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 58149311042     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.10.011     Document Type: Article

References (29)

1. Steffel J., Lüscher T.F., and Tanner F.C. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 113 (2006) 722-731
2. Wilcox J.N., Smith K.M., Schwartz S.M., and Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc. Natl. Acad. Sci. 86 (1989) 2839-2843
3. Steffel J., Hermann M., Greutert H., Gay S., Lüscher T.F., Ruschitzka F., et al. Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation. Circulation 111 (2005) 1685-1689
4. Steffel J., Akhmedov A., Greutert H., Lüscher T.F., and Tanner F.C. Histamine induces tissue factor expression: implications for acute coronary syndromes. Circulation 112 (2005) 341-349
5. Reddy K.V., Bhattacharjee G., Schabbauer G., Hollis A., Kempf K., Tencati M., et al. Dexamethasone enhances LPS induction of tissue factor expression in human monocytic cells by increasing tissue factor mRNA stability. J. Leukoc. Biol. 76 (2004) 145-151
6. Toschi V., Gallo R., Lettino M., Fallon J.T., Gertz S.D., Fernández-Ortiz A., et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 95 (1997) 594-599
7. Steffel J., Latini R.A., Akhmedov A., Zimmermann D., Zimmerling P., Lüscher T.F., et al. Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design. Circulation 112 (2005) 2002-2011
8. Stähli B.E., Camici G.G., Steffel J., Akhmedov A., Shojaati K., Graber M., et al. Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation. Circ. Res. 99 (2006) 149-155
9. Crawley J.T., and Lane D.A. The haemostatic role of tissue factor pathway inhibitor. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 233-242
10. Pedersen B., Holscher T., Sato Y., Pawlinski R., and Mackman N. A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice. Blood 105 (2005) 2777-2782
11. Badimon J.J., Lettino M., Toschi V., Fuster V., Berrozpe M., Chesebro J.H., et al. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation 99 (1999) 1780-1787
12. Kong W., Wei J., Abidi P., Lin M., Inaba S., Li C., et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 10 (2004) 1344-1351
13. Abidi P., Zhou Y., Jiang J.D., and Liu J. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2170-2176
14. Mackman N. Regulation of the tissue factor gene. FASEB J. 10 (1995) 883-889
15. Ross J. mRNA stability in mammalian cells. Microbiol. Rev. 59 (1995) 423-450
16. Steiner S., Speidl W.S., Pleiner J., Seidinger D., Zorn G., Kaun C., et al. Simvastatin blunts endotoxin-induced tissue factor in vivo. Circulation 111 (2005) 1841-1846
17. Eto M., Kozai T., Cosentino F., Joch H., and Lüscher T.F. Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways. Circulation 105 (2002) 1756-1759
18. Solovey A., Kollander R., Shet A., Milbauer L.C., Choong S., Panoskaltsis-Mortari A., et al. Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin. Blood 104 (2004) 840-846
19. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
20. Steffel J., Iseli S., Arnet C., Lüscher T.F., and Tanner F.C. Cocaine unbalances endothelial tissue factor and tissue factor pathway inhibitor expression. J. Mol. Cell. Cardiol. 40 (2006) 746-749
21. Zeng X., and Zeng X. Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC. Biomed. Chromatogr. 7 (1999) 442-444
22. Brand K., Fowler B.J., Edgington T.S., and Mackman N. Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol. Cell. Biol. 11 (1991) 4732-4738
23. Crossman D.C., Carr D.P., Tuddenham E.G., Pearson J.D., and McVey J.H. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J. Biol. Chem. 265 (1990) 9782-9787
24. Guhaniyogi J., and Brewer G. Regulation of mRNA stability in mammalian cells. Gene 265 (2001) 11-23
25. Garneau N.L., Wilusz J., and Wilusz C.J. The highways and byways of mRNA decay. Nat. Rev. Mol. Cell Biol. 8 (2007) 113-126
26. Ahern S.M., Miyata T., and Sadler J.E. Regulation of human tissue factor expression by mRNA turnover. J. Biol. Chem. 268 (1993) 2154-2159
27. Collins R., Armitage J., Parish S., Sleigh P., Peto R., and Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361 (2003) 2005-2016
28. Vaughan C.J., Murphy M.B., and Buckley B.M. Statins do more than just lower cholesterol. Lancet 348 (1996) 1079-1082
29. Hölschermann H., Schuster D., Parviz B., Haberbosch W., Tillmanns H., and Muth H. Statins prevent NF-kappaB transactivation independently of the IKK-pathway in human endothelial cells. Atherosclerosis 185 (2006) 240-245